# cyrusbio.com > AI-optimized mirror of cyrusbio.com containing 25 pages totalling 4,394 words of clean markdown content, structured data, and semantic HTML. Original source: https://cyrusbio.com/. Last updated: 2026-06-15T17:31:19.196Z. Each page is available as HTML (with JSON-LD structured data) and Markdown (text-only, ideal for LLMs and RAG). ## Homepage - [Cures by Design](/content/site-root.html): Cyrus Bio is a computationally-driven discovery company focused on naturally existing proteins that show the potential to be turned into superior therapeutics (200 words) ## Articles & Blog Posts - [2025/01/13/index.html](/content/2025/01/13/index.html) (1 words) - [Prediction of protein mutational free energy: benchmark and sampling improvements increase classification accuracy](/content/prediction-of-protein-mutational-free-energy-benchmark-and-sampling-improvements-increase-classification-accuracy.html): SEATTLE, WA March 20, 2020 — Software to predict the change in protein stability upon point mutation is a valuable tool for a number of biotechnological and (343 words) - [2024/12/11/index.html](/content/2024/12/11/index.html) (1 words) - [Cyrus, the Broad team up to make in vivo CRISPR use safer — (FierceBiotech)](/content/cyrus-the-broad-team-up-to-make-in-vivo-crispr-use-safer-via-fiercebiotech.html): https://www.fiercebiotech.com/biotech/cyrus-broad-team-up-to-make-vivo-crispr-use-safer (61 words) - [A Safer CRISPR? Cyrus, Broad Institute Look to Quell Concerns — (Xconomy)](/content/a-safer-crispr-cyrus-broad-institute-look-to-quell-concerns-via-xconomy.html): https://xconomy.com/national/2019/12/03/a-safer-crispr-cyrus-broad-institute-look-to-quell-concerns/ (59 words) - [2024/10/11/index.html](/content/2024/10/11/index.html) (1 words) - [News](/content/news/page/3/index.html): Director of Discovery Dr. Erik Procko recently performed a presentation on Cyrus’ novel IgG-degrading IdeS enzyme development candidates at PepTalk Conference (333 words) - [2024/11/12/index.html](/content/2024/11/12/index.html) (1 words) - [News](/content/news/page/2/index.html): Director of Discovery Dr. Erik Procko recently performed a presentation on Cyrus’ novel IgG-degrading IdeS enzyme development candidates at PepTalk Conference (298 words) - [2024/12/13/index.html](/content/2024/12/13/index.html) (1 words) - [News](/content/news/page/5/index.html): Director of Discovery Dr. Erik Procko recently performed a presentation on Cyrus’ novel IgG-degrading IdeS enzyme development candidates at PepTalk Conference (228 words) - [Cyrus Biotechnology to Present Its Novel IgG-degrading IdeS Enzyme Development Candidates for Autoimmune Indications at PepTalk Conference in San Diego](/content/cyrus-biotechnology-to-present-its-novel-igg-degrading-ides-enzyme-development-candidates-for-autoimmune-indications-at-peptalk-conference-in-san-diego.html): Director of Discovery Dr. Erik Procko recently performed a presentation on Cyrus’ novel IgG-degrading IdeS enzyme development candidates at PepTalk Conference (102 words) - [Cyrus Biotechnology Announces Potent in vivo Redosability of an Engineered IdeS Protease for IgG-driven Autoimmune Disease, Demonstrating No Anti-drug Antibodies (Business Wire)](/content/cyrus-biotechnology-announces-potent-in-vivo-redosability-of-an-engineered-ides-protease-for-igg-driven-autoimmune-disease-demonstrating-no-anti-drug-antibodies-business-wire.html): Read article at the link below: (75 words) - [Cyrus Biotechnology Announces Selection of CYR212 as Clinical Candidate for Chronic IgG-driven Autoimmune Disease Including Myasthenia Gravis and Immune Thrombocytopenia (Business Wire)](/content/cyrus-biotechnology-announces-selection-of-cyr212-as-clinical-candidate-for-chronic-igg-driven-autoimmune-disease-including-myasthenia-gravis-and-immune-thrombocytopenia-business-wire.html): Article can be read via the following link: (76 words) - [Cyrus Biotechnology Congratulate Co-Founder David Baker on 2024 Nobel Prize in Chemistry](/content/cyrus-biotechnology-congratulate-co-founder-david-baker-on-2024-nobel-prize-in-chemistry-business-wire.html): Cyrus co-founder and Computational Biologist David Baker was recently awarded as a 2024 Nobel Laureate in Chemistry. Congratulations to David on receiving (99 words) - [financial-conflict-of-interest-policy/index.html](/content/financial-conflict-of-interest-policy/index.html) (1 words) - [contact/index.html](/content/contact/index.html) (1 words) - [About](/content/about/index.html): World-class protein design innovators backed by top-tier global investors. (256 words) - [Cyrus Biotechnology Spins out Levitate Bio, a Protein AI, Bioinformatics, and Rosetta Service Provider, to Bring Automated, Customized AI Solutions to Biopharma Drug Discovery](/content/cyrus-biotechnology-spins-out-levitate-bio-a-protein-ai-bioinformatics-and-rosetta-service-provider-to-bring-automated-customized-ai-solutions-to-biopharma-drug-discovery.html) (71 words) - [Cyrus Biotechnology to Present its Protein Engineering Capability, Immunogenicity Risk Mitigation, and Best-in-Class IgG Protease Candidate at Hit ID Summit (Business Wire)](/content/cyrus-biotechnology-to-present-its-protein-engineering-capability-immunogenicity-risk-mitigation-and-best-in-class-igg-protease-candidate-at-hit-id-summit-business-wire.html): Cyrus CSO and co-founder Yifan Song performed a presentation at the Hit ID Summit in Boston, speaking on a few topics including Cyrus' hybrid AI/screening (122 words) - [Platform](/content/platform/index.html): AI, Rosetta, and lab-based large-scale screening. (913 words) - [News](/content/news/index.html): Director of Discovery Dr. Erik Procko recently performed a presentation on Cyrus’ novel IgG-degrading IdeS enzyme development candidates at PepTalk Conference (311 words) - [Pipeline](/content/pipeline/index.html): Cyrus is advancing biologics for IgG mediated autoimmune disease (IdeS enzyme), Acute Respiratory Distress Syndrome (ACE2v2), Infectious Disease (CMV) (550 words) - [IdeS](/content/ides/index.html): IgG depletion for auto-immune diseases. (290 words) ## Resources - [Full Page Index](/index.html): Browse all cached pages with rich metadata - [About This Cache](/content/about.html): Methodology, technical details, and usage guidelines - [XML Sitemap](/sitemap.xml): Machine-readable sitemap for crawler discovery - [Robots.txt](/robots.txt): Crawler directives